Achieve Life Sciences appoints Goldberg as CEO, names two leaders to board

Achieve Life Sciences (ACHV) announced it has appointed Andrew Goldberg, MD, as Chief Executive Officer and as a member of the Board of Directors, effective following the closing of Achieve’s recently announced financing. Most recently, Goldberg served as a Portfolio Manager at Marshall Wace and previously as a Partner at Vivo Capital. Achieve has also appointed the following individuals to serve as members of the Company’s Board of Directors, effective upon the closing of the financing: Lucian Iancovici, MD: Managing Director at TPG. Aaron E. Royston, MD: Managing Partner at venBio.